David Warnock, MD, Professor of Medicine (Emeritus), University of Alabama at Birmingham, discusses the Fabry disease landscape.

Fabry disease is a rare genetic, multisystemic lysosomal disease characterized by specific cutaneous, neurological, renal, cardiovascular, cochleo-vestibular, and cerebrovascular manifestations.

Dr. Warnock describes recent advancements in the treatment of Fabry disease, including two enzyme treatments and a chaperone therapy. While these treatment options provide hope for patients and a base for research, there are still unmet clinical needs in this population.

свернуть